Recurrent pericardial effusion after cardiac surgery: the use of colchicine after recalcitrant conventional therapy
Authors:
Open Access
- 10 August 2011
- journal article
- case report
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 6 (1) , 96
Abstract
Pericardial effusion represents a common postoperative complication in cardiac surgery. Nonetheless, it can be resistant to conventional therapy leading to prolonged in-hospital stay and worsening of clinical conditions.Keywords
This publication has 18 references indexed in Scilit:
- Rationale and design of the COPPS trial: a randomised, placebo-controlled, multicentre study on the use of colchicine for the primary prevention of postpericardiotomy syndromeJournal of Cardiovascular Medicine, 2007
- CORP (COlchicine for Recurrent Pericarditis) and CORP-2 trials – two randomized placebo-controlled trials evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of recurrent pericarditis: study design and rationaleJournal of Cardiovascular Medicine, 2007
- Pericardial DiseaseCirculation, 2006
- Colchicine in Addition to Conventional Therapy for Acute PericarditisCirculation, 2005
- Pretreatment with corticosteroids attenuates the efficacy of colchicine in preventing recurrent pericarditis: a multi-centre all-case analysisEuropean Heart Journal, 2005
- Relapsing pericarditisHeart, 2004
- Guidelines on the Diagnosis and Management of Pericardial Diseases Executive SummaryThe Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of CardiologyEuropean Heart Journal, 2004
- Colchicine Treatment for Recurrent PericarditisCirculation, 1998
- Recurrent pericarditis. Relief with colchicine.Circulation, 1990
- COLCHICINE FOR RECURRENT PERICARDITISThe Lancet, 1987